Co-founder, Sunil Gandhi Ph.D., Presents at the 20th Annual Advanced Imaging Methods Workshop

by
Translucence Biosystems
February 20, 2023

Dr. Sunil Gandhi, Co-Founder of Translucence Biosystems, recently presented his work with CTO Dr. Ricardo Azevedo at the 20th Annual Advanced Imaging Methods Workshop hosted by the CRL Molecular Imaging Center at the University of California, Berkeley.

In his presentation, Dr. Gandhi introduced a new statistical toolkit for analyzing cellular resolution fluorescence images in atlas-aligned, light-sheet imaged mouse brains. The toolkit, which uses a Bayesian model, accounts for common sources of error and increases detection power over standard parametric statistics corrected for multiple comparisons. Dr. Gandhi demonstrated the toolkit's ability to analyze recent neuronal activity in mouse brains using markers of immediate early gene expression.

This work provides a useful tool for extracting actionable data from brain-wide images and advances the field of cellular imaging.

To learn more, stay tuned for a recording of Dr. Gandhi's presentation– coming soon!

Ask your question

Send us your questions and we will get back to you as soon as possible
info@translucencebio.com

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

March 23, 2023

CEO, Damian Wheeler Ph.D., Presents at the BIO-SEE 2023 Webinar Series

At the BIO-SEE 2023 Webinar Series, Damian Wheeler Ph.D., CEO of Translucence Biosystems, presented the company's innovative approach to brain-wide single-cell imaging in a talk entitled "Brain-wide single-cell resolution imaging and machine learning-enabled quantification".
by
Translucence Biosystems
January 31, 2023
Updates

Translucence Biosystems Sponsors 20th Annual Advanced Imaging Methods Workshop

Translucence Biosystems was proud to sponsor the 20th Annual Advanced Imaging Methods Workshop, an event that brought together researchers and industry leaders to share the latest advancements in imaging technology.
by
Translucence Biosystems
January 31, 2023
Updates

Translucence Biosystems Participates in Keystone Meeting on Drug Delivery to the Brain

Our team has been working with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. Our CEO, Damian Wheeler, Ph.D. presented our findings in our poster titled the "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."
by
Translucence Biosystems